CisFRad (GORTEC 2015-02)
Radiother Oncol 2024 Aug:197:110329. doi: 10.1016/j.radonc.2024.110329. Epub 2024 May 19
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial
Christian Borel, Xu-Shan Sun, Alexandre Coutte, Guillaume Bera, Christian Sire, Sylvie Zanetta, Marc Alfonsi, Guillaume Janoray, Thierry Chatellier, Muriel Garcia-Ramirez, Elisabeta Gherga, Yasser Hammoud, Mickaël Burgy, Nelly Etienne-Selloum, Adeline Pechery, Marie-Hélène Girard-Calais, Michel Velten, Jean-Pierre Pignon, Mathilde Wanneveich, Jean Bourhis